Cronos Group Inc. (CRON) - Long-Term Debt to Capital

Cronos Group Inc. (CRON) generates its core income from the sale of medical products and foreign exports, while the 0.00 indicator captures the current status of the metric. The asset's market value dynamics link these successes to personnel, as the company attracts scientists through a combination of a startup atmosphere and strict regulatory compliance. The business is based on high-tech substance extraction at facilities in Israel and Canada with support from Altria.

This indicator compares long-term debt obligations to total equity, determining the extent of the business's reliance on external borrowed financing for long-term planning. By analyzing the share of long-term loans within the capital structure, an investor assesses the resilience of Cronos Group Inc. (CRON) to stress scenarios, which is critical when scaling global brands through the partnership with Altria Group and expanding distribution.